INCR InterCure: Nilai bisnis marang pendapatan

InterCure Ltd (INCR) - logo korporat

InterCure Ltd. is pursuing expansion into Asian and European markets, although it currently relies on its dominance in Israel through premium pricing. The EV-to-revenue multiple smooths this contrast, where the value of 1097.26 characterizes this level of market valuation. The stability of the indicator confirms balanced sales, while the introduction of new brands and CNS clinical trials drive commercial development.

Nilai perusahaan marang pendapatan InterCure Ltd. (INCR): kanggo periode 23.11.2025 - 20.11.2026

Canndoc - rincian analitis lan metrik utama (INCR)

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Pambiji fundamental:Canndoc INCR
Sampel barang InterCure Ltd

The EV/Sales ratio compares the total enterprise value of a business, including debt, to its annual revenue, allowing for an assessment of the market value of one dollar of sales regardless of financial leverage. For InterCure Ltd., whose resilience is based on the diversification of medical product imports in Israel, the EV/Sales ratio trend serves as an indicator of how the market values the efficiency of complex logistics management and the protection of supply chains.